Anti-muscarinic drugs can be effective in treating the symptoms of DYT1 dystonia and DYT1-torsinA transgenic mice are reported to show an abnormal interplay between the dopaminergic and cholinergic systems in electrophysiological studies [24], [25], [26]. The gene discussed is TOR1A; the disease is early-onset generalized limb-onset dystonia.